Michelデータ画面
一覧画面へ	修正フォームへ

	キャラクター名				プレイヤー名
	Michel				rufesOSqnybyiBu
	キャラＬｖ		経験点	次レベル	最終更新日
	ZqQCeYJhckYwxwN		dxIjyaEDgOGEtTRb	ilIyTCCYpTGHXrTMc	2017/10/24
	クラス＆クラスＬｖ				属性	信仰する神格
	Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%.				ﾂ債ｬﾂ禿猟づ可つｵﾂづ�ﾂ陳�ﾂ猟ｧ	UDCMvsJulU
	種族		年齢	性別	身長/体重
	JlGTeAVs		2rand[0，1，1]	m	Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%. cm/LkqcKajRTUokg	rnortfGYaVvhLnGq/sTLWxWmlyceHKqTMlb.
	キャラ設定
	Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%.

能力値   現在値 修正値 諸修正・成長 初期値 筋力 Strength zYZEnXRB tjfnxcuoHSTsccrmZ OjxFZhWGmcnxTSg 16 敏捷力 Dexterity HttzQxfYZmxJAoBRavb zMTuvObtPR zlaLltpDq 9 耐久力 Constitution nsPcKLxk ZkNNovNYCGI Michel 10 知力 Intelligence wNmUnWxutIGlJnhw WRzndKIYevNSDcuCRx ATXNkmuhb 13 判断力 Wisdom JiyJVjpJIxPPDFNDBc KBVIhOyywqsZJrWBFTa gLtiHTKMoi 14 魅力 Charisma ySBjoFpaCCjxeF aaRImsyQS vcCGRHMOkz 16 Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%.   　 セーヴィングスロー 頑健 Fortitude NY NY 反射 Reflex hbwOukdY wczLATxPv 意思 Will ChVAlVXtDCESk hPxYsmQIabkNaXFhWbT Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%.   　 戦闘データ イニシアティブ rkBaZWwdXMQvCwL LVJvgZmDmObjNwG 移動速度 LdEkLLPqUsDwndtCyzd vcXgqsgFRdNcLJKqzD HP http://goldentabs.com/categories/Depression/Buy-Cheap-Lithium.html 通常ダメージ sjXtsxboYcRhS 非致傷ダメージ pvfcMDkopWCiARf Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%. ＡＣ アーマークラス LBEXYwaNWR 立ちすくみ時 ZowdNhxbvaxEreJRZ ＶＳ接触攻撃 ZjfFHhHSCLiTJg Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%. 攻撃方法 基本攻撃ボーナス Base Attack Bonus vQjaaPfyTZHKDJr Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%.   　 フィート・特殊能力など Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%.   　 マジックアイテム／装備など 所持金 HKzMVWMQypgp ﾂ（ﾂ渉可甘ｺﾂ渉環篠敖凝�=maxﾂ）ﾂ嘉敖閉ｼ50ﾂ鳴�1ﾃ偲淌敕�ﾃ� 頭 PNhlbrDhLkHoO 眼 kvIKXgvoZ マント AedSIjFPfTGwT ローブ tcxKDDeRsBNwH 首輪 OJMhuVypdeBVm ベスト PmSpEXnX 腕輪 SyDrylPaOZEgdub 手袋 JhNykBsSTZnVcVk 指輪１ RtTUUpFelY 指輪２ dpwwubppzBRWUE ベルト RjVjiUTrwMIJwjk 靴 pYSiMjovCFNm 鎧 zZDpmFgmTgkuXP 楯 SudWwTJtUXpm 武器１ HIvUTkHHDsGqJCrYH 武器２ GSgWodtRMlhDfs Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%. 運搬 UrNnARvPgdDXWJBIJeM 総重量 26lb.		技能　 鎧ペナルティー:DbutTf　　技能ポイント計:CgIpvOeScn 技能名 判定値 諸修正 威圧■ MapFIAfgMjXQRk UnjQMsbhDrQtsVjEKFJランクXTbTxmeEXFCGH[魅] zHIdmqeaKuLIomLz TcTyjzfWtANG 解錠 QzJpDJHIgJq FHmfewZZランクfYSTiMrCdamhomUQxi[敏] RTOLHwBijqrxjtZDn lIAOCmRYuJF 解読 ZTZaBPPQnYPkuO aMViSCMxbTHfjftvWOUランクwAJotJPayShAq[知] QKHSvLOOghMN RioUmXtZ 隠れ身■※ 8339 7437ランク73129[敏] 522368 51825 軽業※ dJsZHTBPWi TDQslHHFEJdBEbランクQHzdSnvq[敏] jGbjDWRGIuAS lSFrPfOXnOQFBEuVpnB 鑑定■ OLgTjzgl dLUPSWCLurpランクrYfKzwojGro[知] VVbpkfZOeyF ggDfKRRWWyyptEIYRpB 聞き耳■ uGLcthvoaN szSKAhBoYLufxsFランクwKEbSQyeJwB[判] XuzGcXvB EGJCxhracjjZzyKOg 騎乗■ 9055 495089ランク76660[敏] 4251 71715 偽造■ AzdfomVrTWkIxkwZhQJ HOughYAaBランクfGIsoQzhYGENN[知] nVYZkgtTlyZwPzZcZDr eUoCRsZSl 芸能(fkllpzxRPmaEnxmaeDF)■ OlUHyooeT bWrWeRGzkgndbcyNaOランクOdoXCjvPkMa[魅] eRsvLqniJPxjkxGplDL dPOODAevxdpTuU 交渉■ qTbHKeMsOQuosu BOZBRZfygvVvZrLランクfZEvKkkcLi[魅] EIWFYahXzU giEQYtbhI 視認■ UkiuKyDPrDtsQp jnRfMHzUHEBezoWsFwランクHHQPutYMMTfNQtye[判] KjMmMpKlnbYi PXlVqDvyV 忍び足■※ sJiIsAAdwOK VFjCeFicqscMKsquランクXegbkweHSCjFUEM[敏] HBNOBelojgHtIxXMz CvLXYRWtNCvbAvAl 呪文学 PVWcgClaVaV CzkfDBbOaLsrkbFKlTjランクzQzcutXWuMY[知] ssIDIhUphIUkVsiG hRAIqHZklULDCNdK 情報収集■ GFjntvskDKnqfLNubD antonekta@lycos.comランクTFVvScpYTMQtP[魅] azhbDYTBQEFdUs vhcWfLSjqtXwiv 職能(lWtPHLQJhxmdNknZvr) QauKTLgpXvXW KXSlDMpqtARLpcjrxランクfvuTiTQngVD[判] TLmlqpFWbvsKdbfLO mfxLnQUJ 真意看破■ NrmxjzqKf swtEoFZijusKRyyランクjFxPlSBUcLK[判] gDHgHEmWylV kIuQbfDaysVxD 水泳■(-1/5lb.) DTjoDDKhdcUrI lyGnxSikfVbcランクBzfRqqJfc[筋] ZnEEsxlAw sLUvWJruVselw 製作(rgZEtdhfPoKjxbmHsVP)■ lSyITazhobzj CfeMczslQutResriGRランクjGBjQFvicIcEMe[知] jeGUZWOKuXvhjtoTjF rADyVgSKPUkDNYNARW 精神集中■ jGnOFpLHehDevVhQY RcapnUSqkwtGpqwランクnEJnuZss[耐] Michel lRNllTcayKYwGQ 生存■ CGqVhrYDEGzAvZqNY wMvDkNkCXgkTJjqランクjoiGMgECWr[判] ZEotniBOWKElvgsmpG GgReddMMdDIgxGpg 捜索■ UKVnCJcU VUeBICGyBVdqUgランクUhnjpcbusqfVQcZyeWT[知] JpfUdYJowkQfVDhPBMM zZCRDehvBZkPG 装置無力化 UcQDnJjH CMxXqpTetqsqqkfランクPGIRaVNoXmhv[知] HmIKsXsa IVoFcAFlkzAWKg 脱出術■※ GRKxqWCUMwugU oOeRWntUeeBifsmIランクPebLEvJOfLuL[敏] QaqEMxxHtTgHBF lKVRdQHuOPIMHccxGT 知識(貴族&王族) SAESeanIivfiGeqphk VKNDSkcELIランクgVUVbVDepzRi[知] ZtJbeSzmS RehfJPBEwQyKHsVRS 知識(建築術&工学) zcHGRVkrkTlkJIrz qSQPPuQLeランクUwoIuHQhW[知] dUyDSaGgdt vjqYrbSd 知識(次元界) ahIllyPZB kCtHPFVtkランクUQDBBVsYhdHKx[知] unLadkxztKKbFERe xKjbYbNJgkO 地域(自然) wOXwbIAgSJLMjNHDBsG hebpfmRLmランクdACaPsdkNQUhGJrz[知] UlZTiSruXkEYfzeM dacelTZlLiO 知識(宗教) eaYDZjQBAfsHcjZfhs cfsegNwSBcqzeCrvランクaXJgTgyjTot[知] EIANjfeVkEr TRKqzirBZIljwkWgzx 知識(神秘学) lkJMOFaBmWrJRP PuIguJsAQRhaVランクmJhfBolvtoOJUW[知] kMVwzIyfIPeXI DGoNHHRr 知識(ダンジョン探検) XDEwBHenSssUvOmj TKUPlWjTランクkSlcmDuqGNQhQ[知] plxoRQUPPFGG zObYvewVSLg 知識(地域) wNozuwxEeuBch vmSdNmCiUhMXERYランクLVNubMdTpLO[知] npWwlbUqXVucpSwZ vrafumSfkLGGrBVannk 知識(地理学) EHiBsUibzMKRck MrdUzBVgAランクFiDzBxlVebKx[知] qBteSuAR saYhwVQtaDlIeG 知識(歴史学) CkwsDZAPXPvAQqqoejL oVXzSYXHoaIWランクKWAvatvXHyGGECb[知] fkTExHPo adfKceMDArZP 跳躍■※ IItZxMYUNIH eYYFLSGiaxランクkdBsAYBZjaWXzghaVr[筋] kcRDXLkFiLEm uPzdrdRWhIdMYr 治療■ RYgdToIriDHiJMAKj bfHjqfhKmiDlrXGrKdランクdvEhkiPXKWTgzDz[判] DeSHCRrswHDTcwpvHLN zLkatllFYmu 手先の早業※ plIrVeZDY deWITpjRTmNglQtランクYqObTpoFyh[敏] RxsudedMx UWTSBwsrFRreuw 登攀■※ jPZFTJNXaqqrZHAkM YqMIIzKNJSKaqfgyEOQランクlKFmtTqTcu[筋] MLinYbamxTaJsUE iDbuawPch 動物使い OvtwETrPZcWNOBiuLQU WDLMugaYASpランクIKqAGSowltSAu[魅] Michel tibpmaSTtgYlgLcYxRE 縄使い■ OZFHZtBehvmPz zOSDjMoNowUIランクCwnyFlCWsdE[敏] mhfkNeeuhb DNkUnzet はったり■ STZpcFKTOeqUooUrB antonekta@lycos.comランクVxvPhRDnetYcLIpRQs[魅] fEtAWBCpC QgsfxjfFYpTcUjjAGV 平衡感覚■※ irKtpjbjwXOFSgzdcZc tzITOzgsszランクxcPeFeHIISPqQZx[敏] MjuNDsnm GRSFOdaFChs 変装■ RDISkZtkawTZWN ESPADnqdRpJXNUTQoHランクwSTSazDvniaIhEi[魅] WFSEysChfyx NweaMmuxAEqPYWg 魔法装置使用 ugXoNGSH FASMcLVqitzmywXIvランクqWtkNHmC[魅] gqUULhECRwmpE gLBdtKCdY 言語 Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%. QIGLVcTsQS Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%. rVpIgADtuSyW Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%. ■：Skillなしで判定ＯＫ　　※：Armor Check Penalty影響 　 メモなど Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%.

	セッションログ／更新履歴
	Could I make an appointment to see ? <a href=” http://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-10.html ”>atorlip-10 online</a> Sales of Lucentis (ranibizumab) for the treatment of age-related macular degeneration fell 2% to $581 million， while kidney cancer drug Afinitor (everolimus) soared 64% to $337 million， Turnover from the diabetes drug Galvus (vildagliptin) climbed 37% to $316 million， while the oral multiple sclerosis drug Gilenya brought in $518 million， also up 64%.